Urine for the diagnosis of tuberculosis: Current approaches, clinical applicability, and new developments

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 3, 2010, Pages 262-270

  Peter, Jonathan ^a   Green, Clare ^c,d   Hoelscher, Michael ^e,f   Mwaba, Peter ^d   Zumla, Alimuddin ^c,d   Dheda, Keertan ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF ZAMBIA   (Zambia)

^e Medical Research Programme   (Tanzania)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Diagnosis; Lipoarabinomannan; Mycobacterial DNA; PCR; Tuberculosis; Urine

Indexed keywords

BACTERIAL DNA; LIPOARABINOMANNAN;

CD4 LYMPHOCYTE COUNT; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MYCOBACTERIUM TUBERCULOSIS; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS; URINALYSIS;

DNA, BACTERIAL; FORECASTING; HUMANS; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; URINALYSIS; URINE;

EID: 77951058614     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328337f23a     Document Type: Review

References (54)

1. WHO. Global tuberculosis control: surveillance, planning, financing: WHO report 2009. World Health Organisation; Geneva; 2009.
2. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub- Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357:1519-1523.
3. Garcia GF, Moura AS, Ferreira CS, Rocha MO. Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression. Rev Soc Bras Med Trop 2007; 40:622-626.
4. Davies PD, Pai M. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis 2008; 12:1226-1234.
5. Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009; 15:188-200.
6. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006; 6:423-432. (Pubitemid 44174346)
7. Mortier E, Pouchot J, Girard L, et al. Assessment of urine analysis for the diagnosis of tuberculosis. BMJ 1996; 312:27-28.
8. Nour EM, Cherian BP, Quantrill SJ. Diagnostic yield of early morning urine samples in the diagnosis of tuberculosis. QJM 2007; 100:464-465.
9. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991; 70:384-397.
10. Monkongdee P, McCarthy KD, Cain KP, et al. Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med 2009; 180:903-908.
11. Parker M. Compliment fixation with urine in tuberculosis. Am Rev Tuberc 1931; 23:733-738.
12. Chan J, Fan XD, Hunter SW, et al. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 1991; 59:1755-1761.
13. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004; 53:391-403
14. Hamasur B, Bruchfeld J, Haile M, et al. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 2001; 45:41-52.
15. Tessema TA, Hamasur B, Bjun G, et al. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis 2001; 33:279-284.
16. Boehme C, Molokova E, Minja F, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005; 99:893-900.
17. Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem 1986; 261:12345-12351.
18. Daffe M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 1998; 39:131-203.
19. Lee RE, Brennan PJ, Besra GS. Mycobacterium tuberculosis cell envelope. Curr Top Microbiol Immunol 1996; 215:1-27.
20. Moreira LO, Mattos-Guaraldi AL, Andrade AF. Novel lipoarabinomannan-like lipoglycan (CdiLAM) contributes to the adherence of Corynebacterium diphtheriae to epithelial cells. Arch Microbiol 2008; 190:521-530.
21. Dheda K, Davids V, Lenders L, et al. Clinical Utility of a Commercial LAMELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples. PLoS ONE 2010; 5:e9848.
22. Daley P, Michael JS, Hmar P, et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis 2009; 13:989-995.
23. Mutetwa R, Boehme C, Dimairo M, et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis 2009; 13:1253-1259.
24. Reither K, Saathoff E, Jung J, et al. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis 2009; 9:141.
25. Shah M, Variava E, Holmes CB, et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting. J Acquir Immune Defic Syndr 2009.
26. Lawn SD, Edwards DJ, Kranzer K, et al. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009; 23.
27. Lawn SD, Butera ST, Shinnick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 2002; 4:635-646.
28. Doublier S, Zennaro C, Spatola T, et al. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIV-associated nephropathy. AIDS 2007; 21:423-432.
29. Sittampalam GS, Smith WC, Miyakawa TW, et al. Application of experimental design techniques to optimize a competitive ELISA. J Immunol Methods 1996; 190:151-161.
30. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359:2059-2064.
31. Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIVassociated tuberculosis epidemic in resource-limited settings. Clin Chest Med 2009; 30:685-699; viii.
32. Dheda K, Booth H, Huggett JF, et al. Lung remodeling in pulmonary tuberculosis. J Infect Dis 2005; 192:1201-1209.
33. Lawn SD, Wilkinson RJ, Lipman MC, Wood R. Immune reconstitution and 'unmasking' of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008; 177:680-685.
34. Dhasmana DJ, Dheda K, Ravn P, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 2008; 68:191-208.
35. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20:1605-1612.
36. Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007; 21:713-719.
37. Frieden TR, Sterling TR, Munsiff SS, et al. Tuberculosis. Lancet 2003; 362:887-899.
38. Sada E, Brennan PJ, Herrera T, Torres M. Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J Clin Microbiol 1990; 28:2587-2590.
39. Sada E, Aguilar D, Torres M, Herrera T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol 1992; 30:2415-2418.
40. Pereira Arias-Bouda LM, Nguyen LN, Ho LM, et al. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol 2000; 38:2278-2283.
41. Patel VB, Bhigjee AI, Paruk HF, et al. Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Res 2009; 6:13.
42. Dheda K, Van-Zyl Smit RN, Sechi LA, et al. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 2009; 4:e4689.
43. Sechi LA, Pinna MP, Sanna A, et al. Detection of Mycobacterium tuberculosis by PCR analysis of urine and other clinical samples from AIDS and non-HIVinfected patients. Mol Cell Probes 1997; 11:281-285.
44. Green C, Huggett JF, Talbot E, et al. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis 2009; 9:505-511.
45. Kafwabulula M, Ahmed K, Nagatake T, et al. Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. Int J Tuberc Lung Dis 2002; 6:732-737.
46. Melkonyan H, Feaver JW, Meyer E, et al. Transrenal nucleic acids: from proof of principle to clinical tests. Problems and solutions. Ann N Y Acad Sci 2008; 1137:73-81.
47. Cannas A, Goletti D, Giradi E, et al. Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2008; 12:146-151.
48. Shekhtman EM, Kalpana A, Melkonyan H, et al. Optimization of transrenal DNA analysis: detection of fetal DNA in maternal urine. Clin Chem 2009; 55:723-729.
49. Gopinath K, Singh S. Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis. Int J Infect Dis 2009; 107:425-435.
50. Garton NJ, Waddell SJ, Sherratt AL, et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 2008; 5:e75.
51. Huggett JF,Green C, Zumla A. Nucleic acid detection and quantification in the developing world. Biochem Soc Symp 2009; 37:419-423.
52. Napolitano DR, Pollock N, Kashino SS, et al. Identification of Mycobacterium tuberculosis ornithine carboamyltransferase in urine as a possible molecular marker of active pulmonary tuberculosis. Clin Vaccine Immunol 2008; 15:638-643.
53. Fend R, Kolk AH, Bessant C, et al. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol 2006; 44:2039-2045.
54. Boehme CC, Nabeta P, Henostroza G, et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007; 45:1936-1940.